Monitoring treatment with 5-Azacitidine by flow cytometry predicts duration of hematological response in patients with myelodysplastic syndromeDolores Subirá, Dunia de Miguel, Uta Oelschlaegel et al.|Annals of Hematology|2021Cited by 7